Age at transplantation and outcome after autologous stem cell transplantation in elderly patients with multiple myeloma

Hematology/ Oncology and Stem Cell Therapy

Volumn 4, Issue 1, 2011, Pages 30-36

  Cheikh, Jean El ^a   Kfoury, Elias ^a   Calmels, Boris ^a   Lemarie, Claude ^a   Stoppa, Anne Marie ^a   Bouabdallah, Reda ^a   Coso, Diane ^a   de Collela, Jean Marc Schiano ^a   Ladaique, Patrick ^a   Gastaut, Jean Albert ^a   Mohty, Mohamad ^a   Chabannon, Christian ^a   Blaise, Didier ^a  

^a INSTITUT PAOLI CALMETTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; PREDNISONE; VINCRISTINE;

ADULT; AGED; AGING; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER CENTER; CANCER MORTALITY; CAUSE OF DEATH; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; DRUG MEGADOSE; FEMALE; FOLLOW UP; GERIATRIC PATIENT; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIPLE MYELOMA; OVERALL SURVIVAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 79956067774     PISSN: 16583876     EISSN: None     Source Type: Journal    
DOI: 10.5144/1658-3876.2011.30     Document Type: Article

References (28)

1. Badros A, Barlogie B, Siegel E, Morris C, Desi-Kan R, Zangari M et al. Autologous Stem Cell Trans-Plantation In Elderly Multiple Myeloma Patients Over The Age Of 70 Years. Br J Haematol 2001; 114: 600-607.
2. Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, et al. Review Of 1027 Patients With Newly Diagnosed Multiple Myeloma. Mayo Clin Proc 2003; 78: 21-33.
3. Blade J, Munoz M, Fontanillas M, San Miguel J, Alcala A, Maldonado J, et al. Treatment Of Multiple Myeloma In Elderly People: Long-Term Results In 178 Patients. Age Ageing 1996; 25: 357-361.
4. Rodon P, Linassier C, Gauvain JB, Benboubker L, Goupille P, Maigre M, et al. Multiple Myeloma In Elderly Patients: Presenting Features And Outcome. Eur J Haematol 2001; 66: 11-17.
5. Clavio M, Casciaro S, Gatti AM, Spriano M, Bonanni F, Poggi A, et al. Multiple Myeloma In The Elderly: Clinical Features And Response To Treatment In 113 Patients. Haematologica 1996; 81: 238-244.
6. O'Shea D, Giles C, Terpos E, Perz J, Politou M, Sana V, et al. Predictive Factors For Survival In My-Eloma Patients Who Undergo Autologous Stem Cell Transplantation: A Single-Centre Experience In 211 Patients. Bone Marrow Transplant 2006; 37: 731-737.
7. Palumbo A, Bringhen S, Petrucci MT, Musto P, Rossini F, Nunzi M, et al. Intermediate-Dose Mel-Phalan Improves Survival Of Myeloma Patients Aged 50 To 70: Results Of A Randomized Controlled Trial. Blood 2004; 104: 3052-3057.
8. Siegel DS, Desikan KR, Mehta J, Singhal S, Fas-Sas A, Munshi N, et al. Age Is Not A Prognostic Vari-Able With Autotransplants For Multiple Myeloma. Blood 1999; 93: 51-54.
9. Desikan KR, Tricot G, Munshi NC, Anaissie E, Spoon D, Fassas A, et al. Preceding Chemo- Therapy, Tumor Load And Age Influence Engraft- Ment In Multiple Myeloma Patients Mobilized With Granulocyte Colony-Stimulating Factor Alone. Br J Haemato 2001; 112: 242-247.
10. Fietz T, Rieger K, Dimeo F, Blau IW, Thiel E, Knauf WU. Stem Cell Mobilization In Multiple My- Eloma Patients: Do We Need An Age-Adjusted Regi-Men For The Elderly? J Clin Apher 2004; 19: 202-207.
11. Guba SC, Vesole Dh, Jagannath S, Bracy D, Barlogie B, Tricot G. Peripheral Stem Cell Mobiliza-Tion And Engraftment In Patients Over Age 60. Bone Marrow Transplant 1997; 20: 1-3.
12. Dumontet C, Ketterer N, Espinouse D, Neidhardt EM, Moullet I, Thieblemont C et al. Reduced Pro-Gression-Free Survival In Elderly Patients Receiving Intensification With Autologous Peripheral Blood Stem Cell Reinfusion For Multiple Myeloma. Bone Marrow Transplant 1998; 21: 1037-1041.
13. Storer BE. Estimation Of Failure Probabilities In The Presence Of Competing Risks: New Representa-Tions Of Old Estimators. Stat Med. 1999 Mar 30;18 (6):695-706.
14. Kaplan, E.L. & Meier, P. (1958) Non-Parametric Es-Timation From Incomplete Observations. Journal Of The American Statistical Association, 53, 457±481.
15. Cohen HJ, Bartolucci A. Age And The Treatment Of Multiple Myeloma. South Eastern Cancer Study Group Experience. Am J Med 1985; 79: 316-324.
16. Palva I P, Ahrenberg P, Ala-Harja K, Almqvist A, Hanninen A, Ilvonen M et al. Treatment Of Multiple Myeloma In Old Patients. Finnish Leukaemia Group. Eur J Haematol 1989; 43: 328-331.
17. Sirohi B, Powles R, Treleaven J, Mainwaring P, Kulkarni S, Pandha H, et al. The Role Of Autologous Transplantation In Patients With Multiple Myeloma Aged 65 Years And Over. Bone Marrow Transplant 2000; 25: 533-539.
18. Reece DE, Bredeson C, Perez WS, Jagannath S, Zhang MJ, Ballen KK, et al. Autologous Stem Cell Transplantation In Multiple Myeloma Patients < 60 Vs >/= 60 Years Of Age. Bone Marrow Trans-Plant 2003; 32: 1135-1143.
19. 2) Supported By Autologous Stem Cell Transplantation Is Safe And Effective In Elderly (> Or = 65 Years) Myeloma Patients: Comparison With Younger Patients Treated On The Same Protocol. Bone Marrow Transplant 2006; 37: 917-922.
20. Extermann M. Measurement And Impact Of Co-Morbidity In Older Cancer Patients. Crit Rev Oncol Hematol 2000; 35: 181-200.
21. Yancik R, Havlik RJ, Wesley MN, Ries L, Long S, Rossi Wk, et al. Cancer And Comorbidity In Older Patients: A Descriptive Profile. Ann Epidemiol 1996; 6: 399-412.
22. Lenhoff S, Hjorth M, Westin J, Brinch L, Back-Strom B, Carlson K, et al. Impact Of Age On Survival After Intensive Therapy For Multiple Myeloma: A Population-Based Study By The Nordic Myeloma Study Group. Br J Haematol 2006; 133: 389-396.
23. Terpos E, Apperley JF, Samson D, Giles C, Crawley C, Kanfer E, et al. Autologous Stem Cell Transplantation In Multiple Myeloma: Improved Survival In Nonsecretory Multiple Myeloma But Lack Of Influence Of Age, Status At Transplant, Previ- Ous Treatment And Conditioning Regimen. A Single- Centre Experience In 127 Patients. Bone Marrow Transplant 2003; 31: 163-170.
24. Inouye SK, Peduzzi PN, Robison JT, Hughes JS, Horwitz RI, Concato J. Importance Of Functional Measures In Predicting Mortality Among Older Hos-Pitalized Patients. Jama 1998; 279: 1187-1193.
25. Extermann M, Overcash J, Lyman GH, Parr J, Balducci L. Comorbidity And Functional Status Are Independent In Older Cancer Patients. J Clin Oncol 1998; 16: 1582-1587.
26. Repetto L, Fratino L, Audisio RA, Venturino A, Gianni W, Vercelli M, et al. Comprehensive Geriatric Assessment Adds Information To Eastern Coopera-Tive Oncology Group Performance Status In Elderly Cancer Patients: An Italian Group For Geriatric On-Cology Study. J Clin Oncol 2002; 20: 494-502.
27. Cesari M, Kritchevsky SB, Penninx BW, Nick-Las BJ, Simonsick EM, Newman AB, et al. Prognos-Tic Value Of Usual Gait Speed In Well-Functioning Older People - Results From The Health, Aging And Body Composition Study. J Am Geriatr Soc 2005; 53: 1675-1680.
28. Bensinger WI. Stem-Cell Transplantation For Multiple Myeloma In The Era Of Novel Drugs. J Clin Oncol. 2008 Jan 20; 26(3):480-92. Epub 2007 Dec 3.